These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 35381402)

  • 1. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming.
    Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z
    Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
    Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
    Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
    [No Abstract]   [Full Text] [Related]  

  • 3. A bioprinted sea-and-island multicellular model for dissecting human pancreatic tumor-stroma reciprocity and adaptive metabolism.
    Li M; Freeman S; Franco-Barraza J; Cai KQ; Kim A; Jin S; Cukierman E; Ye K
    Biomaterials; 2024 Oct; 310():122631. PubMed ID: 38815457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours.
    Huang HC; Sung YC; Li CP; Wan D; Chao PH; Tseng YT; Liao BW; Cheng HT; Hsu FF; Huang CC; Chen YT; Liao YH; Hsieh HT; Shih YC; Liu IJ; Wu HC; Lu TT; Wang J; Chen Y
    Gut; 2022 Sep; 71(9):1843-1855. PubMed ID: 34921062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma.
    Xiao H; Li X; Li B; Zhong Y; Qin J; Wang Y; Han S; Ren J; Shuai X
    Acta Biomater; 2023 Apr; 161():265-274. PubMed ID: 36893956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroma-targeting strategies in pancreatic cancer: a double-edged sword.
    Liu X; Iovanna J; Santofimia-Castaño P
    J Physiol Biochem; 2023 Feb; 79(1):213-222. PubMed ID: 36580230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition.
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA;
    Cancer Res; 2021 Jul; 81(13):3461-3479. PubMed ID: 33980655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer stroma: an update on therapeutic targeting strategies.
    Hosein AN; Brekken RA; Maitra A
    Nat Rev Gastroenterol Hepatol; 2020 Aug; 17(8):487-505. PubMed ID: 32393771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy.
    Yu Q; Qiu Y; Li J; Tang X; Wang X; Cun X; Xu S; Liu Y; Li M; Zhang Z; He Q
    J Control Release; 2020 May; 321():564-575. PubMed ID: 32112854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment.
    Luo Y; Li C; Zhang Y; Liu P; Chen H; Zhao Z; Wang Y; Zhou Z; Song H; Su B; Li C; Li X; Zhang T; You H; Wu Y; Tian Z; Zhang S; Guo Y; Fan H; Chen Q; Jiang C; Sun T
    Acta Biomater; 2023 Sep; 167():387-400. PubMed ID: 37276955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer.
    Feng J; Xu M; Wang J; Zhou S; Liu Y; Liu S; Huang Y; Chen Y; Chen L; Song Q; Gong J; Lu H; Gao X; Chen J
    Biomaterials; 2020 May; 241():119907. PubMed ID: 32120315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of an in vitro 3D PDAC stroma rich spheroid model.
    Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
    Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer.
    Tsujii S; Serada S; Fujimoto M; Uemura S; Namikawa T; Nomura T; Murakami I; Hanazaki K; Naka T
    Mol Cancer Ther; 2021 Dec; 20(12):2495-2505. PubMed ID: 34583978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer.
    Zhu Y; Fang S; Fan B; Xu K; Xu L; Wang L; Zhu L; Chen C; Wu R; Ni J; Wang J
    Theranostics; 2024; 14(4):1683-1700. PubMed ID: 38389839
    [No Abstract]   [Full Text] [Related]  

  • 16. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors.
    Zinger A; Koren L; Adir O; Poley M; Alyan M; Yaari Z; Noor N; Krinsky N; Simon A; Gibori H; Krayem M; Mumblat Y; Kasten S; Ofir S; Fridman E; Milman N; Lübtow MM; Liba L; Shklover J; Shainsky-Roitman J; Binenbaum Y; Hershkovitz D; Gil Z; Dvir T; Luxenhofer R; Satchi-Fainaro R; Schroeder A
    ACS Nano; 2019 Oct; 13(10):11008-11021. PubMed ID: 31503443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy.
    He X; Chen X; Liu L; Zhang Y; Lu Y; Zhang Y; Chen Q; Ruan C; Guo Q; Li C; Sun T; Jiang C
    Adv Sci (Weinh); 2018 May; 5(5):1701070. PubMed ID: 29876225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy.
    Qu C; Yuan H; Tian M; Zhang X; Xia P; Shi G; Hou R; Li J; Jiang H; Yang Z; Chen T; Li Z; Wang J; Yuan Y
    ACS Nano; 2024 Feb; 18(5):4019-4037. PubMed ID: 38253029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix modulating enzyme functionalized biomimetic Au nanoplatform-mediated enhanced tumor penetration and synergistic antitumor therapy for pancreatic cancer.
    Yang XY; Zhang JG; Zhou QM; Yu JN; Lu YF; Wang XJ; Zhou JP; Ding XF; Du YZ; Yu RS
    J Nanobiotechnology; 2022 Dec; 20(1):524. PubMed ID: 36496411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblasts in pancreatic cancer: molecular and clinical perspectives.
    Rebelo R; Xavier CPR; Giovannetti E; Vasconcelos MH
    Trends Mol Med; 2023 Jun; 29(6):439-453. PubMed ID: 37100646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.